Over 80 A-share companies have submitted applications to the Hong Kong Stock Exchange this year

Recently, following the submission of a listing application to the Hong Kong Stock Exchange by the leading A-share recombinant protein drug company, Sinovac Biotech, the leading A-share medical device company, Mindray, has also officially submitted a listing application to the Hong Kong Stock Exchange. According to incomplete statistics, more than 80 A-share listed companies have submitted applications to the Hong Kong Stock Exchange this year. With companies like Seres and Joyson Electronics consecutively listing on the Hong Kong Stock Exchange, the number of companies achieving "A+H" listings this year has reached 16, bringing the total number of "A+H" listed companies to over 160. (Shanghai Securities Journal)